Panbela Therapeuticsの利益マージン
Panbela Therapeuticsの利益マージンは何ですか。
Panbela Therapeutics Inc.の利益マージンは0.00%です。
利益マージンの定義は何ですか。
利益マージンは、収益性の尺度であり、収益の割合として純利益を求めることによって計算されます。
Profit margin is calculated with the selling price (or revenue) taken as base times 100. It is the percentage of selling price that is turned into profit. Profit percentages are calculated to find the ratio of profit to cost of an investment. Profit margin is an indicator of a company's pricing strategies and how well it controls costs. Differences in competitive strategy and product mix cause the profit margin to vary among different companies. The profit margin is used mostly for internal comparisons. It is difficult to accurately compare the net profit ratio for different entities. Individual businesses' operating and financing arrangements vary so much that different entities are bound to have different levels of expenditure, so that comparison of one with another can have little meaning. A low profit margin indicates a low margin of safety: higher risk that a decline in sales will erase profits and result in a net loss, or a negative margin.
NASDAQのセクタHealth Careにおける利益マージンの企業と比べるPanbela Therapeutics
Panbela Therapeuticsは何をしますか。
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Panbela Therapeuticsと類似の利益マージン
- Sys plcの利益マージンは-0.03%です。
- e LDLC societe anonymeの利益マージンは-0.03%です。
- IntegraGen SAの利益マージンは-0.03%です。
- Live Ventures Incの利益マージンは-0.03%です。
- Ever-Glory Internationalの利益マージンは-0.03%です。
- Titagarh Wagonsの利益マージンは-0.02%です。
- Panbela Therapeuticsの利益マージンは0.00%です。
- Orange Belgium S.Aの利益マージンは0.00%です。
- Amrapali Industriesの利益マージンは0.00%です。
- Kandi Technologies Incの利益マージンは0.01%です。
- Responsive Industriesの利益マージンは0.01%です。
- Stellantis N.Vの利益マージンは0.01%です。
- Adams Resources &の利益マージンは0.01%です。